Emerging Microbes and Infections

SJR Rank #1,134H-index: 115SJR: 2.269Best quartile: Q1Open AccessAPC: US$2,643Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.751.52.253

Subject Categories

  • Drug DiscoveryQ1
  • EpidemiologyQ1
  • ImmunologyQ1
  • Infectious DiseasesQ1
  • Medicine (miscellaneous)Q1
  • MicrobiologyQ1
  • ParasitologyQ1
  • VirologyQ1

Areas: Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

SARS-CoV-2 and COVID-19 ResearchViral Infections and VectorsViral gastroenteritis research and epidemiologyInfluenza Virus Research StudiesMosquito-borne diseases and controlAnimal Disease Management and EpidemiologyCOVID-19 Clinical Research StudiesRespiratory viral infections researchAnimal Virus Infections StudiesViral Infections and Immunology Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

20222025070140210280

Detailed Information

ISSN

2222-1751

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.71

References per Document

44.08

Coverage

2012-2026

Scope

As an international peer reviewed journal, the mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency. The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and thus EMI is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years. EMI will cover relevant topics of critical biological and clinical value including, but not limited to: epidemic surveillance; clinical manifestation; diagnosis and management; cellular and molecular pathogenesis; innate and acquired immune responses between emerging microbes and their hosts; drug discovery, and vaccine development

Metrics from SCImago Journal Rank 2025. View on SCImago